These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16148160)

  • 1. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury.
    Offner H; Subramanian S; Wang C; Afentoulis M; Vandenbark AA; Huan J; Burrows GG
    J Immunol; 2005 Sep; 175(6):4103-11. PubMed ID: 16148160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
    Wang C; Gold BG; Kaler LJ; Yu X; Afentoulis ME; Burrows GG; Vandenbark AA; Bourdette DN; Offner H
    J Neurochem; 2006 Sep; 98(6):1817-27. PubMed ID: 16899071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
    J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
    Sinha S; Miller L; Subramanian S; McCarty OJ; Proctor T; Meza-Romero R; Huan J; Burrows GG; Vandenbark AA; Offner H
    J Neuroimmunol; 2010 Aug; 225(1-2):52-61. PubMed ID: 20546940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
    Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis.
    Santambrogio L; Crisi GM; Leu J; Hochwald GM; Ryan T; Thorbecke GJ
    J Neuroimmunol; 1995 May; 58(2):211-22. PubMed ID: 7759610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
    J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
    Leva G; Klein C; Benyounes J; Hallé F; Bihel F; Collongues N; De Seze J; Mensah-Nyagan AG; Patte-Mensah C
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3016-3027. PubMed ID: 28899788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
    J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
    Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA
    J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
    Karpus WJ; Kennedy KJ; Smith WS; Miller SD
    J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms.
    Stern JN; Illés Z; Reddy J; Keskin DB; Sheu E; Fridkis-Hareli M; Nishimura H; Brosnan CF; Santambrogio L; Kuchroo VK; Strominger JL
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11743-8. PubMed ID: 15292514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.